ITGA9
Basic information
Region (hg38): 3:37452115-37823507
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ITGA9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 17 | |||||
missense | 56 | 68 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 4 | 2 | 6 | |||
non coding | 3 | |||||
Total | 0 | 0 | 56 | 16 | 16 |
Variants in ITGA9
This is a list of pathogenic ClinVar variants found in the ITGA9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-37452394-C-G | not specified | Uncertain significance (Nov 03, 2022) | ||
3-37452400-G-A | not specified | Uncertain significance (Jul 12, 2022) | ||
3-37452408-A-C | Likely benign (Jan 19, 2018) | |||
3-37452439-T-G | not specified | Uncertain significance (Nov 16, 2021) | ||
3-37471048-C-G | not specified | Uncertain significance (Dec 18, 2023) | ||
3-37471115-C-A | ITGA9-related disorder | Benign (Dec 31, 2019) | ||
3-37473363-G-T | not specified | Uncertain significance (Aug 26, 2022) | ||
3-37473369-C-T | ITGA9-related disorder | Likely benign (Feb 11, 2022) | ||
3-37473453-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
3-37481496-C-T | not specified | Uncertain significance (Apr 25, 2023) | ||
3-37481497-G-A | not specified | Uncertain significance (Jan 04, 2024) | ||
3-37481522-C-T | Likely benign (Nov 01, 2023) | |||
3-37481523-G-A | not specified | Uncertain significance (Feb 26, 2024) | ||
3-37481544-T-C | not specified | Uncertain significance (Aug 02, 2023) | ||
3-37494493-C-G | not specified • ITGA9-related disorder | Benign (Mar 28, 2016) | ||
3-37494565-C-T | not specified | Benign (Mar 28, 2016) | ||
3-37503245-C-A | not specified | Uncertain significance (Dec 08, 2023) | ||
3-37503251-A-G | not specified | Uncertain significance (Dec 20, 2023) | ||
3-37506010-G-A | Benign (Jun 08, 2018) | |||
3-37506014-G-A | not specified | Uncertain significance (Oct 25, 2022) | ||
3-37506062-C-T | not specified | Uncertain significance (Nov 03, 2022) | ||
3-37508581-G-A | not specified | Uncertain significance (Jul 19, 2023) | ||
3-37508604-A-G | not specified | Uncertain significance (Mar 19, 2024) | ||
3-37508677-T-A | not specified | Benign (Feb 09, 2017) | ||
3-37513782-C-T | not specified | Uncertain significance (Sep 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ITGA9 | protein_coding | protein_coding | ENST00000264741 | 28 | 371400 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00816 | 0.992 | 125720 | 0 | 28 | 125748 | 0.000111 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.627 | 532 | 574 | 0.926 | 0.0000349 | 6774 |
Missense in Polyphen | 182 | 224.06 | 0.8123 | 2640 | ||
Synonymous | -1.00 | 245 | 226 | 1.08 | 0.0000153 | 2012 |
Loss of Function | 4.99 | 15 | 54.9 | 0.273 | 0.00000280 | 650 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000268 | 0.000268 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.0000984 | 0.0000967 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Integrin alpha-9/beta-1 (ITGA9:ITGB1) is a receptor for VCAM1, cytotactin and osteopontin. It recognizes the sequence A-E- I-D-G-I-E-L in cytotactin. {ECO:0000250}.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Cell adhesion molecules (CAMs) - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Dilated cardiomyopathy (DCM) - Homo sapiens (human);Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Integrin-mediated Cell Adhesion;Arrhythmogenic Right Ventricular Cardiomyopathy;Focal Adhesion;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;Developmental Biology;Integrin cell surface interactions;Extracellular matrix organization;Integrin;Signal transduction by L1;Arf6 trafficking events;L1CAM interactions;Plexin-D1 Signaling;Axon guidance;ECM proteoglycans;Alpha9 beta1 integrin signaling events;Beta1 integrin cell surface interactions
(Consensus)
Recessive Scores
- pRec
- 0.283
Intolerance Scores
- loftool
- 0.555
- rvis_EVS
- -1.1
- rvis_percentile_EVS
- 6.95
Haploinsufficiency Scores
- pHI
- 0.157
- hipred
- Y
- hipred_score
- 0.668
- ghis
- 0.566
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.751
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Itga9
- Phenotype
- immune system phenotype; vision/eye phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- itga9
- Affected structure
- lymphangioblast cord
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- cell adhesion;integrin-mediated signaling pathway;extracellular matrix organization;neutrophil chemotaxis;wound healing
- Cellular component
- plasma membrane;integrin complex;basal plasma membrane;integrin alpha9-beta1 complex
- Molecular function
- collagen binding;laminin binding;metal ion binding